Apex Capital Management’s Idexx Laboratories IDXX Stock Holding History

Apex Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$40M	Buy	510,565 +15,756	+3%	+$1.13M	0.88%	51
2015 Q4	$36.1M	Buy	494,809 +1,572	+0.3%	+$112K	0.81%	50
2015 Q3	$36.6M	Buy	+493,237	New	+$35.3M	0.83%	49

Other funds holding IDXX

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Apex Capital Management's IDXX Position: Q1 2016 in Review

Apex Capital Management increased its Idexx Laboratories (IDXX) stake by 3.2% in Q1 2016, buying an estimated $1.13M and bringing the position to 510,565 shares worth $40M. The position accounts for 0.88% of the portfolio, ranked #51.

Apex Capital Management first reported a position in IDXX in Q3 2015 and has held it in 3 quarters since. 377 funds tracked by Wall St. Rank hold IDXX as of Q1 2016.

Apex Capital Management held 510,565 shares of Idexx Laboratories worth $40M as of Q1 2016.
Apex Capital Management bought 15,756 Idexx Laboratories shares in Q1 2016, an estimated $1.13M.
Idexx Laboratories made up 0.88% of Apex Capital Management's portfolio in Q1 2016, its #51 holding.
Apex Capital Management first reported a position in Idexx Laboratories in Q3 2015 and has held it in 3 quarters since.
377 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2016.

Based on Apex Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.